China Universal Asset Management Co., Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 4,176 shares of MDGL stock, worth $1.45 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,176
Previous 2,504
66.77%
Holding current value
$1.45 Million
Previous $701,000
26.39%
% of portfolio
0.1%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$861 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$709 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$705 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$693 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$686 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.94B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...